2001

Aug 10, 2001
Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents

Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...

Jul 24, 2001
Guidant Announces Worldwide Launch of New Self-Expanding Stent System

New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...

Jul 18, 2001
Guidant Introduces its New Generation of Heart Failure Therapy

European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...

Jul 17, 2001
Guidant Reports Second Quarter Sales of $656 Million

Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...

Jul 17, 2001
Physicians Resume Implants with Guidant's ANCURE System

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...

Show 5102550100 per page
Top